Insider Trading Activity For AdvanSource Biomaterials Corp. (OTCMKTS:ASNB)
Michael F Adams , CEO of AdvanSource Biomaterials Corp. (OTCMKTS:ASNB) reportedly Bought 10,000 shares of the company’s stock at an average price of 0.08 for a total transaction amount of $800.00 SEC Form
Insider Trading History For AdvanSource Biomaterials Corp. (OTCMKTS:ASNB)
Analyst Ratings For AdvanSource Biomaterials Corp. (OTCMKTS:ASNB)
These are No ratings tracked in the last 12 months. .
The current consensus rating for AdvanSource Biomaterials Corp. (OTCMKTS:ASNB) is N/A (Score: NaN) with a consensus target price of N/A
Recent Trading Activity for AdvanSource Biomaterials Corp. (OTCMKTS:ASNB)
Shares of AdvanSource Biomaterials Corp. closed the previous trading session at 0.0850 down -0.0030 -3.41% with 15,790 shares trading hands.